from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3508/PE_PGRS54

LFCtreatmentdescriptionclass of inhibitor

-0.078

Amikacinug/mL Amikacintranslation

-2.330

Cap5-10ug/mL Capreomycintranslation

-1.017

Rox10-50 ug/mL Roxithromycintranslation

-0.598

SM2-5 ug/mL Streptomycintranslation

0.036

Tet5-10 ug/mL Tetracyclinetranslation

-1.603

Rif0.2-5ug/mL Rifampicintranscription

-1.796

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.723

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.009

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.228

CPZ10-50 ug/mL Chlorpromazinerespiration

0.074

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.146

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.622

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.727

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.343

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.278

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.021

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.189

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.777

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.884

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.201

KCN5-20 ug/mL Potassium cyaniderespiration

0.663

NaN30.2-2 mM Sodium aziderespiration

-0.181

Nigericin50 uM Nigericinrespiration

-0.242

TRC10-150 ug/mL Triclosanrespiration

-0.676

TRZ10-25 ug/mL Thioridazinerespiration

-1.043

Valinomycin0.5-10 uM Valinomycinrespiration

0.255

ZnSO42 mM ZnSO4respiration

-0.821

menadione6-10 ug/mL Menadionerespiration

0.357

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.210

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.308

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.131

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.468

NRP_1Non-replicating persistence stage 1dosRassociated

-0.085

Amp0.2mg/mL AmpicillincellWall

-0.170

Cephalexin20-100 ug/mL CephalexincellWall

-1.438

Cerulenin0.32-5 ug/mL CerulenincellWall

0.140

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.187

EMB10-20 ug/mL EthambutolcellWall

-0.044

Eta12-40 ug/mL EthionamidecellWall

0.713

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.233

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.542

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.442

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.438

BZA0.12 mg/mL BenzamidearomaticAmides

0.734

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.184

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.680

H2O24 mM hydrogen peroxideDNAdamaging

-1.091

Levo10 ug/mL LevofloxacinDNAdamaging

0.092

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.765

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.505

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.538

UVUV-irradiationDNAdamaging

-0.382

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.202

Antimycin12.5-50 ug/mL Antimycin A?

-0.583

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.406

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.019

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.598

PA8240.2-2 ug/mL PA-824?

0.656

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.332

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.005

Verapamil50 uM Verapamil?

-0.276

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.612

methoxatin10-20 ug/mL Methoxatin?